Since January 2010
Advising on and Control of health care spending and long-term sick leave, member of the Belgian governement advising comittee on the reimbursement of medicines (CTG/CRM at RIZIV/INAMI)
Director New Product Planning CNS
January 2005 --- January 2010
Strategic driver in multidisciplinary teams for new CNS compounds in clinical development a.o. in Epilepsy, Multiple Sclerosis, Alzheimer Disease; in preclinical research and for licensing-in candidates.
Global Brand Manager CNS
January 2002 --- January 2004
International marketing of a new anti-epileptic drug (Keppra®), premarketing of new indications.
International Medical Advisor CNS
January 2000 --- January 2002
International medical marketing to support launch of a new anti-epileptic drug (Keppra®). Set up of Investigator Initiated Studies program and European Medical Science Liaison team.
Business Unit Manager CNS
January 1985 --- January 2000
Creation of the Business Unit Organization Promotion of existing products and launch of new medicines in the field of Neuropsychiatry (Alzheimer's disease, Parkinson's disease, Epilepsy, Schizophrenia). Launch of 2 innovative drugs: Exelon® for the treatment of Alzheimer's and Comtan® for the treatment of Parkinson's disease. Responsible for a team of Specialist Medical Representatives and Product Managers.
January 1984 --- November 1985
Full time independent practice in Leuven 1984-1985 Currently Licensed in General Medicine Medical examiner for glider pilots
Analytical thinkingCritical thinkingEfficiencyIndependenceInterest in knowledgeResult Oriented
CNSBusiness IntelligenceBusiness DevelopmentBusiness StrategyCancerCommercializationCompetitive AnalysisCross-functional team leadershipDue DiligenceElectrocardiogram (ECG)EndocrinologyFamily practiceGastroenterologyGlobal MarketingHealthcare ReimbursementImmunologyKOL managementMarketing StrategyMedical affairsNeurologyNeuroscienceNew Business DevelopmentoncologyProduct managementProduct MarketingProject PlanningProject Portfolio ManagementPublic HealthPsychiatrySchizophreniaStrategyStrategic Planning
MD in Medicine from University of Leuven in 1985